Coronary Wave Intensity Analysis as an Invasive and Vessel-Specific Index of Myocardial Viability

Matthew Ryan1, Kalpa De Silva1, Holly Morgan1

  • 1Cardiovascular Division, King's College London, UK (M.R., K.D.S., H.M., K.O., O.M.D., H.R., H.E., M.M., A.M.S., D.P.).

Insights

Coronary wave intensity analysis accurately predicts myocardial viability, matching cardiac MRI performance. This technique could streamline diagnosis and management for ischemic cardiomyopathy patients.

Area of Science:

  • Cardiology
  • Cardiovascular Physiology
  • Diagnostic Imaging

Background:

  • Ischemic cardiomyopathy diagnosis relies on coronary angiography and viability testing, often requiring separate procedures.
  • Current methods lack a single test for both coronary physiology and myocardial viability assessment.
  • Coronary wave intensity analysis (CWIA) interrogates myocardial contractility and microvascular function.

Purpose of the Study:

  • To evaluate CWIA's accuracy in predicting myocardial viability compared to late-gadolinium-enhanced cardiac magnetic resonance imaging (LGE-CMR).
  • To determine if CWIA can serve as a single diagnostic tool for ischemic cardiomyopathy.

Main Methods:

  • Patients with LVEF ≤40% and extensive coronary disease underwent CWIA during cardiac catheterization (rest, hyperemia, dobutamine stress).
  • A dual pressure-Doppler sensing coronary guidewire was used for CWIA.
  • Myocardial viability was assessed by LGE-CMR and functional recovery via echocardiography at 6-month follow-up.

Main Results:

  • Resting backward compression wave energy in viable territories was significantly greater than in nonviable ones (P<0.001).
  • CWIA demonstrated comparable accuracy to LGE-CMR in predicting viability (AUC 0.812 vs. 0.757).
  • A threshold of -2500 W m⁻² s⁻¹ for backward compression wave energy yielded 86% sensitivity and 76% specificity.

Conclusions:

  • Backward compression wave energy measured by CWIA accurately predicts myocardial viability, similar to LGE-CMR.
  • CWIA offers potential to simplify ischemic cardiomyopathy management, akin to FFR's impact on stable angina.
Abstract